The group that backed Novavax’s Covid gambit is tapping another MoCo biotech

The group that backed Novavax’s Covid gambit is tapping another MoCo biotech

bizjournals

Published

The Germantown company develops tests for what it calls “neglected infectious diseases” like Ebola and Zika virus.

Full Article